Detalhe da pesquisa
1.
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 24(10): 1094-1108, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37714168
2.
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design.
Lancet
; 399(10336): 1695-1707, 2022 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35405085
3.
Cabozantinib-nivolumab sequence in metastatic renal cell carcinoma: The CABIR study.
Int J Cancer
; 151(8): 1335-1344, 2022 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35603906
4.
Oncological Outcomes of Delayed Nephrectomy After Optimal Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma.
Eur Urol Oncol
; 5(5): 577-584, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35853818
5.
Abiraterone and Olaparib for Metastatic Castration-Resistant Prostate Cancer.
NEJM Evid
; 1(9): EVIDoa2200043, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-38319800
6.
Feasibility Study and Preliminary Results of Prognostic Value of Bone SPECT-CT Quantitative Indices for the Response Assessment of Bone Metastatic Prostate Carcinoma to Abiraterone.
Front Med (Lausanne)
; 6: 342, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-32039220
7.
[New drugs approval: Lutetium-PSMA in metastatic castration-resistant prostate cancer]. / Nouvelles AMM : Lutetium-PSMA dans les cancers de prostates métastatiques résistants à la castration.
Bull Cancer
; 110(6): 600-602, 2023 06.
Artigo
em Francês
| MEDLINE | ID: mdl-37059642
8.
Management of non-metastatic castrate-resistant prostate cancer: A systematic review.
Cancer Treat Rev
; 70: 223-231, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30300771
9.
Systemic treatments for high-risk localized prostate cancer.
Nat Rev Urol
; 15(8): 498-510, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29765147